← Leaderboards
Donald Lavelle
University Of Illinois At Chicago
$5,608,438
Attributed
$9,065,331
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2012–23$2.5M$1.9M$1.3M$625K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$9,065,331 · 3
By mechanism
U01$5,185,339 · 1
P01$2,318,089 · 1
R01$1,561,903 · 1
Top collaborators
- James Douglas Engel3 shared
- Yogen Saunthararajah3 shared
Most similar at University Of Illinois At Chicago
Same institution · by research overlap
- Yogen Saunthararajah$12,927,987
- Joseph Desimone$3,651,968
- Alan P. Kozikowski$10,594,236
Others in their field
Top investigators on “Papio”
- Larry S. Schlesinger · Texas Biomedical Research Institute$68,853,698
- David H Sachs · Columbia University Health Sciences$22,193,763
- Gary L White · University Of Oklahoma Hlth Sciences Ctr$19,734,225
- Kazuhiko Yamada · Columbia University Health Sciences$16,393,308
- Robert W Gracy · Texas Biomedical Research Institute$16,263,088
- David Kc Cooper · Massachusetts General Hospital$14,929,617
Research focus
PapioCellsAdultModificationGlobinClinical TrialsSickle Cell AnemiaPharmaceutical PreparationsMouse ModelDna Methyltransferase InhibitorGamma GlobinFutureGenesHemoglobin Concentration ResultFda ApprovedFetal HemoglobinInnovationCombinatorialAnimal ModelErythroid DifferentiationDesignDecitabineBeta ThalassemiaEnzymes
Grant awards (12)
Advancing fetal hemoglobin to the clinic using highly predictive in vivo strategies$448,867
P01 · FY2023 · HL · contact PI
Advancing fetal hemoglobin to the clinic using highly predictive in vivo strategies$454,189
P01 · FY2022 · HL · contact PI
Advancing fetal hemoglobin to the clinic using highly predictive in vivo strategies$460,545
P01 · FY2021 · HL · contact PI
Advancing fetal hemoglobin to the clinic using highly predictive in vivo strategies$465,986
P01 · FY2020 · HL · contact PI
Advancing fetal hemoglobin to the clinic using highly predictive in vivo strategies$488,502
P01 · FY2019 · HL · contact PI
Improving HbF induction by inhibiting epigenetic target enzymes$1,736,085
U01 · FY2017 · HL
Improving HbF induction by inhibiting epigenetic target enzymes$1,736,085
U01 · FY2016 · HL
Improving HbF induction by inhibiting epigenetic target enzymes$1,713,169
U01 · FY2015 · HL
5-Hydroxymethylcytosine and Globin Gene Switching$392,768
R01 · FY2015 · HL · contact PI
5-Hydroxymethylcytosine and Globin Gene Switching$390,775
R01 · FY2014 · HL · contact PI
5-Hydroxymethylcytosine and Globin Gene Switching$379,610
R01 · FY2013 · HL · contact PI
5-Hydroxymethylcytosine and Globin Gene Switching$398,750
R01 · FY2012 · HL · contact PI